Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
Evan S. Dellon(University of North Carolina at Chapel Hill), Arsalan Shabbir(Regeneron (United States)), Ikuo Hirano(Northwestern University), Elizabeth Laws(Sanofi (United States)), Jennifer Maloney(Regeneron (United States)), Jennifer D. Hamilton(Regeneron (United States)), Albert J. Bredenoord(Amsterdam Neuroscience), Bethany Beazley(Regeneron (United States)), Jonathan M. Spergel(University of Pennsylvania), David R. Weinreich(Northwestern University), Alfredo J. Lucendo(Hospital General de Tomelloso), Margaret H. Collins(Cincinnati Children's Hospital Medical Center), Brad Shumel(Regeneron (United States)), Matthew P. Kosloski(AbbVie (United States)), Bolanle Akinlade(Regeneron (United States)), Leda Mannent(Sanofi (France)), Mohamed Kamal(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Angeliki Giannelou(Northwestern University), Wei Keat Lim(Northwestern University), Seema S. Aceves(Rady Children's Hospital-San Diego), Eilish McCann(Regeneron (United States)), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Xian Sun(Regeneron (United States)), Nikhil Amin(Northwestern University), Mirna Chehade(Icahn School of Medicine at Mount Sinai), Kiran Patel(Goethe University Frankfurt), Naimish Patel(Sanofi (United States)), Marcella Ruddy(Regeneron (United States)), Matthew F. Wipperman(Regeneron (United States))
Cited by 452
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k